Plant-based Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Plant-based Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global plant-based vaccines market, which amassed revenues of US$ 1.6 billion in 2024, is expected to achieve a valuation of US$ 2.9 billion by the close of 2031. Plant-based vaccines have emerged as a promising avenue for safer, more accessible, and cost-effective vaccine development.

Plant-Based Vaccines: A Paradigm Shift

Traditional vaccine production methods face limitations in developing vaccines for certain deadly diseases. The concept of using plants as bioreactors to produce edible vaccines has gained prominence, offering a cost-effective alternative with easy scalability. Plants like tobacco, maize, potatoes, rice, and tomatoes have served as biofactories for vaccine development.

This technology not only simplifies vaccine production but also facilitates needleless and accessible delivery methods, making it a valuable tool in global healthcare. Notably, plant-based vaccines can play a crucial role in addressing vaccine distribution challenges highlighted during recent global emergencies.

Driving Factors for Plant-Based Vaccine Manufacturers:

Rapid and Cost-Effective Synthesis: Transient expression systems in plant-based vaccine manufacturing can produce target antigens within a week, making them a vital option for rapid vaccine development. This capability is particularly valuable during emergencies like the COVID-19 pandemic, allowing for the swift creation of vaccines.

Scalability and Versatility: Plant-based systems offer the ability to produce up to 10 million vaccine doses per month, making them ideal for mass manufacturing. They can accommodate various vaccine types, including multiepitope vaccines, protein subunits, virus-like particles (VLPs), and chimeric VLPs, ensuring a wide range of vaccine options.

Affordability and Safety: Plant-based vaccine production is cost-effective, scalable, and safe. Moreover, plants enable the synthesis of recombinant proteins post glycosylation, a capability lacking in E. coli-based systems.

Challenges to Plant-Based Vaccine Market Growth:

Efficiency Limitations: Plant-based platforms face efficiency challenges related to modifications, such as glycosylation, gene expression in prokaryotic chloroplasts, and limited trials using nuclear transformation.

Development and Commercialization Gap: A knowledge gap exists between laboratory-based production and the commercialization of plant-based vaccines. This includes challenges in business planning, financing, and regulatory approval.

Country-Wise Insights:
• Booming U.S. Market: The United States witnesses seasonal variations in pathogenic diseases, leading to increased demand for novel plant-based vaccines. Growing R&D and product launches in the country are expected to drive market expansion.
• Lucrative German Market: Germany faces a high burden of viral diseases, including influenza. This high prevalence of influenza is expected to boost demand for plant-based vaccines.
• Emerging Japanese Market: Japan is on the brink of vaccine commercialization approvals. Clinical trials for plant-based COVID-19 vaccines have commenced, and upcoming approvals are expected to drive market growth.

Key Market Players:

Leading companies in the global plant-based vaccines market are focusing on next-generation plant-based expression technologies to expedite vaccine development and provide effective solutions against a range of illnesses.
• Creative Biolabs
• Medicago Inc.
• iBio
• ICON
• EEA Consulting Engineers
• Kentucky BioProcessing, Inc.
• Baiya Phytopharm
• Protalix Biotherapeutics

Key Segments of Plant-Based Vaccines Industry Research

By Type:
• Viral Vaccines
• Bacterial Vaccines
• Others

By Application:
• Influenza
• Zika Virus
• Ebola Virus
• Others

By Source:
• Maize
• Tobacco
• Potatoes
• Others

By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Plant-based Vaccines Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Plant-based Vaccines Market Outlook, 2018 – 2031
3.1. Global Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Viral Vaccines
3.1.1.2. Bacterial Vaccines
3.1.1.3. Others
3.2. Global Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Maize
3.2.1.2. Tobacco
3.2.1.3. Potatoes
3.2.1.4. Others
3.3. Global Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Influenza
3.3.1.2. Zika Virus
3.3.1.3. Ebola Virus
3.3.1.4. Others
3.4. Global Plant-based Vaccines Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Plant-based Vaccines Market Outlook, 2018 – 2031
4.1. North America Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Viral Vaccines
4.1.1.2. Bacterial Vaccines
4.1.1.3. Others
4.2. North America Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Maize
4.2.1.2. Tobacco
4.2.1.3. Potatoes
4.2.1.4. Others
4.3. North America Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Influenza
4.3.1.2. Zika Virus
4.3.1.3. Ebola Virus
4.3.1.4. Others
4.4. North America Plant-based Vaccines Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
4.4.1.2. U.S. Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
4.4.1.3. U.S. Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
4.4.1.4. Canada Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
4.4.1.5. Canada Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
4.4.1.6. Canada Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Plant-based Vaccines Market Outlook, 2018 – 2031
5.1. Europe Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Viral Vaccines
5.1.1.2. Bacterial Vaccines
5.1.1.3. Others
5.2. Europe Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Maize
5.2.1.2. Tobacco
5.2.1.3. Potatoes
5.2.1.4. Others
5.3. Europe Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Influenza
5.3.1.2. Zika Virus
5.3.1.3. Ebola Virus
5.3.1.4. Others
5.4. Europe Plant-based Vaccines Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Germany Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.2. Germany Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.3. Germany Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.4. U.K. Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.5. U.K. Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.6. U.K. Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.7. France Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.8. France Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.9. France Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.10. Italy Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.11. Italy Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.12. Italy Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.13. Turkey Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.14. Turkey Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.15. Turkey Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.16. Russia Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.17. Russia Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.18. Russia Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.19. Rest of Europe Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
5.4.1.20. Rest of Europe Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
5.4.1.21. Rest of Europe Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Plant-based Vaccines Market Outlook, 2018 – 2031
6.1. Asia Pacific Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Viral Vaccines
6.1.1.2. Bacterial Vaccines
6.1.1.3. Others
6.2. Asia Pacific Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Maize
6.2.1.2. Tobacco
6.2.1.3. Potatoes
6.2.1.4. Others
6.3. Asia Pacific Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Influenza
6.3.1.2. Zika Virus
6.3.1.3. Ebola Virus
6.3.1.4. Others
6.4. Asia Pacific Plant-based Vaccines Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. China Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.2. China Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.3. China Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.4. Japan Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.5. Japan Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.6. Japan Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.7. South Korea Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.8. South Korea Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.9. South Korea Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.10. India Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.11. India Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.12. India Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.13. Southeast Asia Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.14. Southeast Asia Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.15. Southeast Asia Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.16. Rest of Asia Pacific Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
6.4.1.17. Rest of Asia Pacific Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
6.4.1.18. Rest of Asia Pacific Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Plant-based Vaccines Market Outlook, 2018 – 2031
7.1. Latin America Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Viral Vaccines
7.1.1.2. Bacterial Vaccines
7.1.1.3. Others
7.2. Latin America Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Maize
7.2.1.2. Tobacco
7.2.1.3. Potatoes
7.2.1.4. Others
7.3. Latin America Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Influenza
7.3.1.2. Zika Virus
7.3.1.3. Ebola Virus
7.3.1.4. Others
7.4. Latin America Plant-based Vaccines Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
7.4.1.2. Brazil Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
7.4.1.3. Brazil Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.4. Mexico Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
7.4.1.5. Mexico Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
7.4.1.6. Mexico Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.7. Argentina Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
7.4.1.8. Argentina Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
7.4.1.9. Argentina Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.10. Rest of Latin America Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
7.4.1.11. Rest of Latin America Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
7.4.1.12. Rest of Latin America Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Plant-based Vaccines Market Outlook, 2018 – 2031
8.1. Middle East & Africa Plant-based Vaccines Market Outlook, by Type, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Viral Vaccines
8.1.1.2. Bacterial Vaccines
8.1.1.3. Others
8.2. Middle East & Africa Plant-based Vaccines Market Outlook, by Source, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Maize
8.2.1.2. Tobacco
8.2.1.3. Potatoes
8.2.1.4. Others
8.3. Middle East & Africa Plant-based Vaccines Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Influenza
8.3.1.2. Zika Virus
8.3.1.3. Ebola Virus
8.3.1.4. Others
8.4. Middle East & Africa Plant-based Vaccines Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. GCC Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
8.4.1.2. GCC Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
8.4.1.3. GCC Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.4. South Africa Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
8.4.1.5. South Africa Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
8.4.1.6. South Africa Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.7. Egypt Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
8.4.1.8. Egypt Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
8.4.1.9. Egypt Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.10. Nigeria Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
8.4.1.11. Nigeria Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
8.4.1.12. Nigeria Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.13. Rest of Middle East & Africa Plant-based Vaccines Market by Type, Value (US$ Bn), 2018 – 2031
8.4.1.14. Rest of Middle East & Africa Plant-based Vaccines Market by Source, Value (US$ Bn), 2018 – 2031
8.4.1.15. Rest of Middle East & Africa Plant-based Vaccines Market by Application, Value (US$ Bn), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Drug vs Type Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Creative Biolabs
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Medicago Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. iBio
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. ICON
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. EEA Consulting Engineers
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Kentucky BioProcessing, Inc.
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Baiya Phytopharm
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Protalix Biotherapeutics
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings